Global Hypothyroidism Market Size, Share, Forecast Report, 2020-2027

Global Hypothyroidism Market is expected to grow significantly over the forecast period. It is projected to grow at a CAGR of 3.7% over the forecast period. -Hypothyroidism is a condition in which the thyroid is underactive or non-active. The most common symptoms of hypothyroidism are weight gain, water retention, constipation, fatigue, daytime sleepiness, and others.

Rising prevalence of hypothyroidism is one of the key factors driving the Hypothyroidism Market. According to a recent article published by the American Thyroid Association, more than 12% of the US population develops a thyroid disorder during their lifetime and similar trend has been observed in different geographies such as UK, India, and others.

Various other factors such as rising awareness about hypothyroidism, developing healthcare infrastructure, increasing research & development activities related to healthcare and favourable reimbursement and funding policies are also expected to propel the growth of the market.

However, the side-effects related to available therapeutics can hamper the market growth over the forecast period. Some of the hypothyroidism drugs in the market such as Synthroid, euthyrox, and others show mild side-effects ranging from fever, headache, insomnia, etc. to tremors, and others. Thus, it is projected that side-effects related to the use of drugs are likely to restrict the market growth.

Segmentation:

The Global Hypothyroidism Market has been segmented into type of hypothyroidism, diagnosis & treatment, route of administration, and end user.The market, on the basis of type of hypothyroidism, has been segmented into primary hypothyroidism, secondary hypothyroidism, and tertiary hypothyroidism.The market, by diagnosis & treatment, has been segmented into diagnosis and treatment. The diagnosis segment is further classified as physical examination, blood tests, imaging scan, and others. The treatment segment is further classified as levothyroxine sodium, liothyronine, and natural desiccated thyroid (NDT).
Key players:

Pfizer Inc., AbbVie Inc., Merck & Co., Inc., ALLERGAN, Mylan N.V., Erfa Canada Inc, Novartis AG, GlaxoSmithKline plc, RLC Labs and others are some of the key players in the Global Hypothyroidism Market.

Global Hypothyroidism Market, by Type of Hypothyroidism:

•       Primary Hypothyroidism
•       Secondary Hypothyroidism
•       Tertiary Hypothyroidism

Global Hypothyroidism Market, by Diagnosis & Treatment:

• Diagnosis
  • Physical Examination
  • Blood tests
  • Imaging Scan
  • Others
• Treatment
  • Levothyroxine Sodium
  • Liothyronine
  • Natural Desiccated Thyroid (NDT)

Global Hypothyroidism Market, by Route of Administration:

•       Oral
•        Intravenous
•        Others

Global Hypothyroidism Market, by End User:

•       Hospitals
•       Clinics
•        Research & Academic Institutes
•        Others

Global Hypothyroidism Market, by Key Players:

•        Medtronic
•        Pfizer Inc.
•        AbbVie Inc.
•        Merck & Co., Inc.
•        ALLERGAN
•        Mylan N.V.
•        Erfa Canada Inc
•        Novartis AG
•        GlaxoSmithKline plc
•        RLC Labs